These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 34644216)
81. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774 [TBL] [Abstract][Full Text] [Related]
82. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920 [TBL] [Abstract][Full Text] [Related]
83. Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon. Sun G; Duan H; Xing Y; Zhang D Cancer Manag Res; 2021; 13():5113-5125. PubMed ID: 34234555 [TBL] [Abstract][Full Text] [Related]
84. Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma. Wei J; Ge X; Qian Y; Jiang K; Chen X; Lu W; Yang H; Fu D; Fang Y; Zhou X; Xiao Q; Tang Y; Ding K Front Immunol; 2024; 15():1291938. PubMed ID: 38312843 [TBL] [Abstract][Full Text] [Related]
85. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma. Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725 [TBL] [Abstract][Full Text] [Related]
86. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis. Dong S; Ding Z; Zhang H; Chen Q Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719 [No Abstract] [Full Text] [Related]
87. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Li X; Lin J; Pan Y; Cui P; Xia J Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477 [No Abstract] [Full Text] [Related]
88. A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes. Lv L; Huang Y; Li Q; Wu Y; Zheng L Technol Cancer Res Treat; 2024; 23():15330338241258570. PubMed ID: 38832431 [No Abstract] [Full Text] [Related]
89. Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma. Mou Z; Yang C; Zhang Z; Wu S; Xu C; Cheng Z; Dai X; Chen X; Ou Y; Jiang H Front Genet; 2020; 11():566918. PubMed ID: 33424916 [TBL] [Abstract][Full Text] [Related]
90. Identification of angiogenesis-related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancer. Wang F; Wang C; Li B; Wang G; Meng Z; Han J; Guo G; Yu B; Wang G Biotechnol Appl Biochem; 2024 Feb; 71(1):45-60. PubMed ID: 37881150 [TBL] [Abstract][Full Text] [Related]
91. A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer. Zhang C; Gou X; He W; Yang H; Yin H Cancer Cell Int; 2020; 20():177. PubMed ID: 32467671 [TBL] [Abstract][Full Text] [Related]
92. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients. Zhang P; Liu G; Lu L Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856 [TBL] [Abstract][Full Text] [Related]
93. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma. Yu J; Yang K; Zheng J; Sun X; Zhao W Gene; 2022 Jan; 808():145990. PubMed ID: 34624456 [TBL] [Abstract][Full Text] [Related]
94. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study. Ding K; Zhou M; Wang H; Zhang S; Metaxas DN Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192 [TBL] [Abstract][Full Text] [Related]
95. Identification of a 6-gene signature predicting prognosis for colorectal cancer. Zuo S; Dai G; Ren X Cancer Cell Int; 2019; 19():6. PubMed ID: 30627052 [TBL] [Abstract][Full Text] [Related]
96. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
97. Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes. Zhou R; Gao Z; Ju Y BMC Bioinformatics; 2022 Oct; 23(1):418. PubMed ID: 36221049 [TBL] [Abstract][Full Text] [Related]
98. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis. Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940 [TBL] [Abstract][Full Text] [Related]
99. Development and validation of a risk prediction model and nomogram for colon adenocarcinoma based on methylation-driven genes. Zhu L; Sun H; Tian G; Wang J; Zhou Q; Liu P; Tang X; Shi X; Yang L; Liu G Aging (Albany NY); 2021 Jun; 13(12):16600-16619. PubMed ID: 34182539 [TBL] [Abstract][Full Text] [Related]
100. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Lin A; Gu T; Hu X; Zhang J; Luo P J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]